Obinutuzumab Biosimilar, Anti-human CD20 Monoclonal Antibody
$175.00 – $1,600.00
Obinutuzumab Biosimilar, CD20 Monoclonal Antibody. The research grade Obinutuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | C057P |
|---|---|
| Product Name | Obinutuzumab Biosimilar, Anti-human CD20 Monoclonal Antibody |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | B-lymphocyte antigen CD20, MS4A1, B1, Bp35, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1, FMC7 |
| Summary | Recombinant Humanized IgG1 Monoclonal Antibody. |
| Source/Host | The anti-human CD20 monoclonal antibody obinutuzumab biosimilar was produced in the obinutuzumab biosimilar CHO stable cell line. |
| Specificity/Sensitivity | The in vivo grade obinutuzumab biosimilar specifically binds to the human type II CD20 antibodies. |
| Applications | ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by obinutuzumab. |
| Form Of Antibody | 0.2 uM filtered solution, pH 6.0, no stabilizers or preservatives. |
| Endotoxin | < 1 EU per 1 mg of the protein by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The research grade obinutuzumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | The research grade Obinutuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C057P: Obinutuzumab Biosimilar, CD20 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Background
Obinutuzumab Biosimilar uses the same protein sequences as the therapeutic antibody obinutuzumab.
Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.
In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.
Syd Labs also provides the following anti-CD20 antibody biosimilar proteins:
Rituximab Biosimilar, research grade, anti-human CD20 monoclonal antibody
Please remember our product information: Obinutuzumab Biosimilar, CD20 Monoclonal Antibody: C057P Syd Labs
Additional information
| Size | 1 mg, 20 mg, 5 mg |
|---|